Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts. First Opinion is STAT ...

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.

The Trump administration this week acknowledged it made a significant error in figures it used to help justify a fraud ...

In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...

CAR-T therapies are continuing to gain traction in autoimmune disease, with a notable new case. Also, the FDA has withdrawn ...

Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

From a scan of its job openings, it would be easy to mistake UnitedHealth Group for Silicon Valley’s latest artificial intelligence juggernaut. Hundreds of postings seek applicants with expertise in ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

You could also catch up on your reading or reach out to someone special. Well, whatever you do, have a grand time. But be ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...